# Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

> **NCT01153750** · PHASE2 · COMPLETED · sponsor: **University Hospital Dresden** · enrollment: 44 (actual)

## Conditions studied

- Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct

## Interventions

- **DRUG:** Glivec

## Key facts

- **NCT ID:** NCT01153750
- **Lead sponsor:** University Hospital Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2010-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01153750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01153750, "Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01153750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*